Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

NGS based Diagnostic Service - MomGuard

MomGuard™ [Next generation birth defect screening test]

First non-invasive prenatal test developed in Korea through NGS technology.

Chromosome aneuploidy test using cell-free DNA in maternal blood.

Characteristics of MomGuard

Own development of high quality NIPT pipeline (diagnostics target, accuracy)
Highly efficient and cost effective analysis platform built by applying proprietary ViaTAG technology
Application of proprietary program GeneBro algorithm, 99% accurate analysis system.

MomGuard™ targets

Down syndrome (Trisomy 21)

Edward syndrome (Trisomy 18) 

Patau syndrome (Trisomy 13)

Sex chromosome aneuploidy